EpicGenetics teams with U of Illinois on test for severe Covid-19

Santa Monica, California-based EpicGenetics Inc. has partnered with the University of Illinois College of Medicine to deploy a test to determine which patients may be at the least at risk for severe and life-threatening cases of Covid-19.   Frederick Behm, head of the University of Illinois College of Medicine at Chicago Department of Pathology, and EpicGenetics CEO Bruce Gillis said they have identified a new application for a blood test EpicGenetics developed to diagnose fibromyalgia, the FM/a…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news